Biopolym. Cell. 2003; 19(3):274-280.
Molecular and Cell Biotechnologies
Overexpression and purification of methionine aminopeptidase from Escherichia coli
1Slavchenko I. Yu., 1Boreyko E. V., 1Vorobey N. V., 1Gavrysh T. G., 1Pehota E. N., 1Kordyum V. A.
  1. PSRS "Biotechnolog"
    150, Akademika Zabolotnogo Str., Kyiv, Ukraine, 03680


Methionine aminopeptidases (MAPs) play an important role in protein processing. In both eukaryotic and prokaryotic cells MAPs selectively remove methionine residue from the N-termini of a nascent polypeptide. However, an extra N-terminal methionyl residue frequently remains in heterologous proteins being produced in bacteria. In case of recombinant proteins destined for clinical application, it is utmost important that the final product has an N-terminal identical to that of a natural counterpart, as otherwise it may possess antigenic properties. An extra N-terminal methionine residue of a recombinant polypeptide may be removed in vitro by treatment with methionine aminopeptidase from E. coli. In the present work, an effective method of this enzyme production has been developed using an expression system based on the bacteriophage T7 polymerase. It was shown, that upon the cultivation of the MAP producer BL (pET-MAP) at 37 В°C the target protein mainly accumulated in an insoluble form with a yield 17 % of the total cellular protein. However, if the producer cells are infected by phage λ, a lysate obtained contains MAP in a soluble form with higher yield compared with non infected cells. Optimization of the conditions such as cells density at the phage infection and temperature of the producer cultivation resulted in the target product yield exceeding 40 % of the soluble cell proteins, or 0,8 g/1. The recombinant protein has been purified by ion-exchange chromatography to homogeneity not less than 90 %.


[1] Datta B. MAPs and POEP of the roads from prokaryotic to eukaryotic kingdoms. Biochimie. 2000;82(2):95-107.
[2] Ben-Bassat A, Bauer K, Chang SY, Myambo K, Boosman A, Chang S. Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure. J Bacteriol. 1987;169(2):751-7.
[3] Hirel PH, Schmitter MJ, Dessen P, Fayat G, Blanquet S. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc Natl Acad Sci U S A. 1989;86(21):8247-51.
[4] Dalb?ge H, Bayne S, Pedersen J. In vivo processing of N-terminal methionine in E. coli. FEBS Lett. 1990;266(1-2):1-3.
[5] Vassileva-Atanassova A, Mironova R, Nacheva G, Ivanov I. N-terminal methionine in recombinant proteins expressed in two different Escherichia coli strains. J Biotechnol. 1999;69(1):63-7.
[6] Sandman K, Grayling RA, Reeve JN. Improved N-terminal processing of recombinant proteins synthesized in Escherichia coli. Biotechnology (N Y). 1995;13(5):504-6.
[7] Solbiati J, Chapman-Smith A, Miller JL, Miller CG, Cronan JE Jr. Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol. 1999;290(3):607-14.
[8] Warren WC, Bentle KA, Schlittler MR, Schwane AC, O'Neil JP, Bogosian G. Increased production of peptide deformylase eliminates retention of formylmethionine in bovine somatotropin overproduced in Escherichia coli. Gene. 1996;174(2):235-8.
[9] Slavchenko IYu, Boreyko EV, Gavrysh TG, Kostyuchenko IP, Kordyum VA. Biosynthesis of human basic fibroblast growth factor in soluble form in Escherichia coli and its purification. Biopolym Cell. 2003; 19(2):179-84.
[10] Chalmers JJ, Kim E, Telford JN, Wong EY, Tacon WC, Shuler ML, Wilson DB. Effects of temperature on Escherichia coli overproducing beta-lactamase or human epidermal growth factor. Appl Environ Microbiol. 1990;56(1):104-11.
[11] Slavchenko IYu. The influence of temperature on the yield soluble human alpha interferon in the system of recombinant proteins overproduction using bacteriophage lambda. Biopolym Cell. 2002; 18(5):436-41.
[12] Cohen SN, Chang AC. Genetic expression in bacteriophage lambda. 3. Inhibition of Escherichia coli nucleic acid and protein synthesis during lambda development. J Mol Biol. 1970;49(3):557-75.
[13] Drahos DJ, Hendrix RW. Effect of bacteriophage lambda infection on synthesis of groE protein and other Escherichia coli proteins. J Bacteriol. 1982;149(3):1050-63.
[14] Kochan J, Murialdo H. Stimulation of groE synthesis in Escherichia coli by bacteriophage lambda infection. J Bacteriol. 1982;149(3):1166-70.
[15] Polissi A, Goffin L, Georgopoulos C. The Escherichia coli heat shock response and bacteriophage lambda development. FEMS Microbiol Rev. 1995;17(1-2):159-69.
[16] Lee KH, Kim HS, Jeong HS, Lee YS. Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli. Biochem Biophys Res Commun. 2002;298(2):216-24.
[17] Chao YP, Chiang CJ, Lo TE, Fu H. Overproduction of D-hydantoinase and carbamoylase in a soluble form in Escherichia coli. Appl Microbiol Biotechnol. 2000;54(3):348-53.
[18] Caspers P, Stieger M, Burn P. Overproduction of bacterial chaperones improves the solubility of recombinant protein tyrosine kinases in Escherichia coli. Cell Mol Biol (Noisy-le-grand). 1994;40(5):635-44.
[19] Luo ZH, Hua ZC. Increased solubility of glutathione S-transferase-P16 (GST-p16) fusion protein by co-expression of chaperones groes and groel in Escherichia coli. Biochem Mol Biol Int. 1998;46(3):471-7.
[20] Machida S, Yu Y, Singh SP, Kim JD, Hayashi K, Kawata Y. Overproduction of beta-glucosidase in active form by an Escherichia coli system coexpressing the chaperonin GroEL/ES. FEMS Microbiol Lett. 1998;159(1):41-6.
[21] Widersten M. Heterologous expression in Escherichia coli of soluble active-site random mutants of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10 by coexpression of molecular chaperonins GroEL/ES. Protein Expr Purif. 1998;13(3):389-95.